Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use JENTADUETO safely and effectively. See full prescribing information for JENTADUETO. JENTADUETO® (linagliptin and metformin hydrochloride tablets), for oral use Initial U.S. Approval: 2012
Medication labelWhy this: Advisory · dailymed-prescription
JENTADUETO is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use JENTADUETO is not recommended in patients with type 1 diabetes mellitus. JENTADUETO has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using JENTADUETO [see Warnings and Precautions (5.2)].
- generic_name
- linagliptin and metformin hydrochloride
- product_names
- linagliptin and metformin hydrochloride
- ndc
- 0597-0146, 0597-0147, 0597-0148, 0597-0147-60, 0597-0147-18, 0597-0147-66, 0597-0148-60, 0597-0148-18, 0597-0148-66, 0597-0146-60, 0597-0146-18, 0597-0146-66
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en